BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15500999)

  • 1. Partial solubility parameters of poly(D,L-lactide-co-glycolide).
    Schenderlein S; Lück M; Müller BW
    Int J Pharm; 2004 Nov; 286(1-2):19-26. PubMed ID: 15500999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
    Young TJ; Johnston KP; Mishima K; Tanaka H
    J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
    Clarke N; O'Connor K; Ramtoola Z
    Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
    Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS
    Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
    Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
    Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.
    Thomasin C; Merkle HP; Gander B
    J Pharm Sci; 1998 Mar; 87(3):269-75. PubMed ID: 9523977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
    Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V
    J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering the drug release profiles of double-layered ternary-phase microparticles.
    Lee WL; Loei C; Widjaja E; Loo SC
    J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation and in-vitro degradation of polylactide and poly(L-lactide-co-glycolide)].
    Wei Z; Liu L; Zhang M; Yang F; Qi M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):122-6. PubMed ID: 18435272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis.
    Murillo M; Irache JM; Estevan M; Goñi MM; Blasco JM; Gamazo C
    Int J Pharm; 2004 Mar; 271(1-2):125-35. PubMed ID: 15129979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submicronparticles from biodegradable polymers.
    Jobmann M; Rafler G
    Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.